Contemporary art collage of hand holding an arrow. Concept of success, opportunity, and growth. Modern design. Copy space. | Photo Credit: beast01
ensex Today, Nifty 50 | Stock Market Live Updates - Find here all the live updates related to Sensex, Nifty, BSE, NSE, share prices and Indian stock markets for 5th May 2026.
- May 5, 2026 06:35
MARKETS at Monday close
Nifty Pharma advances 0.9%, Laurus Labs and Gland Pharma are the top performers
Nifty Energy index snaps 2-session losing streak, gains 0.6%, led by Bharat Heavy Electricals and Calcutta Electric Supply Corp
Nifty Auto gains 0.5%, Eicher and Maruti led the index
Nifty FMCG advances 0.3%, Colgate and Emami led the index
Nifty PSU Bank loses 0.2%, dragged down by Indian Bank and Central Bank
Nifty IT, top sectoral loser, declines 0.9%, dragged by Coforge and TCS
Nifty 50 advances 0.5%, closes below the 24,120 mark
Top Performers: Adani Ports and Jio Financial
Worst Performers: Bharti and Kotak Mahindra Bank
Nifty Bank closes flat
Nifty midcap and Nifty smallcap close in green, advance over 0.7%
Except for PSU bank and IT, all sectoral indices closes in green
Nifty Realty advances 2.5%, Anant Raj and Godrej Properties are the top gainers
Nifty Metal gains 1%, led by Vedanta and Jindal Steel
- May 5, 2026 06:35
ACUTAAS CHEMICALS – CONCALL HIGHLIGHTS
Battery Chemicals Expansion
- Phase1 capex completed at Jhagadia
- 2000MT capacity for VC and FEC
- Fully tied with 3-year contracts
- Production already commenced
- Revenue ramp through FY27
- Phase2 capex by Q1FY27
- Third product capex ongoing
- Two new products planned FY27
CDMO Pipeline
- 4 products validated commercially
- Under regulatory approval stage
- ₹50–100Cr peak revenue each
- Ramp-up expected by FY28
- 10-year supply contract secured
- Strong global client relationship
Growth Outlook
- FY27 revenue growth ~25%
- Consistent decade-long track record
- Three growth engines driving business
- Pharma CDMO largest contributor
- Battery chemicals ramping up
- Semiconductor recovery underway
Margins & Capex
- EBITDA margin ~34.5–35%
- FY27 capex ~₹90Cr planned
- Includes spillover and maintenance
- R&D expansion under consideration
R&D Expansion
- 10x capacity expansion planned
- Multi-sector R&D capabilities
- Pharma, battery, semiconductor focus
- Long-term innovation pipeline
Management Commentary
- Battery and semi become key engines
- Independent growth by FY28 expected
- CDMO ramp steep post commercialization
- Sustained growth visibility
Final Takeaway
- Strong multi-engine growth model
- High-margin specialty chemicals focus
- Execution key for next phase
Disclaimer
- Not a buy/sell recommendation
- May 5, 2026 06:34
Insights: Know 5 governance traps that destroy investor wealth
5 Governance Traps That Destroy Wealth: What SEBI Orders Reveal About Stock Frauds
SEBI orders reveal how companies create, divert or distort value. Learn 5 governance traps and key warning signs investors must watch.
- May 5, 2026 06:33
Natural gas futures: Retain the short position
Natural gas futures: Retain the short position
On the other hand, if natural gas futures rise above the resistance at ₹275, the near-term outlook will turn positive. In such a case, the contract can rally to ₹300. Subsequent resistance is at ₹310
- May 5, 2026 06:32
Trading Guide for May 5, 2026: Intraday supports, resistances for Nifty50 stocks
Day Trading Guide for May 5, 2026: Intraday supports, resistances for Nifty50 stocks
Day Trading Guide gives you the key intraday supports and resistances to watch out for on the Nifty Futures and other widely traded stocks such as Reliance Industries, Infosys, HDFC Bank, TCS, SBI
- May 5, 2026 06:32
Stock to buy today: Laurus Labs (₹1,166.50)
Stock to buy today: Laurus Labs (₹1,166.50) – BUY
Below that ₹1,090 is the next strong support which can limit the downside in case the price declines below ₹1,120. Laurus Labs share price can rise to ₹1,300 in the coming weeks
Published on May 5, 2026